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Abstract
Mesenchymal stem cells (MSCs) derived from various tissues are multi-potency
of self-renewal and differentiation into multi-lineages, including chondrocytes,
adipocytes and osteoblasts in vitro and in vivo. In addition, these cells also display
potent immune regulatory roles that benefit the treatment of inflammatory and
autoimmune diseases. We and others have previously identified that human
gingival-derived mesenchymal stem cells (GMSCs) not only share similar biological
features, but also display some potential advantages compared to other MSC
populations. In the chapter, we have discussed the discovery, phenotypic and func-
tional characteristics, as well as updated the advances of these cell therapies in
immunological diseases.
Keywords: mesenchymal stem cells, gingival-derived mesenchymal stem cells,
inflammatory and autoimmune diseases, immunomodulatory, cell therapy
1. Introduction
Mesenchymal stem cells (MSCs) are pluripotent stem cells derived from meso-
derm with features of self-renewal and multi-lineage differentiation. These
populations include MSCs that are primarily isolated from bone marrow (BMSCs)
[1], fat [2], umbilical cord [3], dental pulp [4] and others [5, 6], particularly in most
of adult tissues. Investigators have reported the successful differentiation of MSCs
into mesenchymal-like cells, such as osteoblasts, chondrocytes, adipocytes [1–6],
neural crest stem-like cells [7] and synoviocytes [8], and manifested that MSCs
maintain immune homeostasis and prevent autoimmunity involving in the repair of
impaired tissues and immunoregulation of autoimmune and inflammatory diseases
[9, 10]. However, the occurrence and development of some autoimmune diseases
are related to MSCs abnormality [11]. In addition, application of cell therapy using
MSCs has weaknesses, like limited large-scale expansion in vitro and vivo [12],
immunological rejection of allogeneic transplant and potential risk on tumorigenesis
[13]. The availability of human gingival mesenchymal stem cells (GMSCs) together
with their potent capacity of self-renewal, proliferation, multi-directional differen-
tiation, inflammatory modulation and less tumorigenesis makes it as an ideal
subtype of MSCs.
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2. Discovery, development and biological characteristic of GMSCs
Gingiva is a unique oral tissue attached to the alveolar bone of tooth sockets,
recognized as a biological mucosal barrier and a distinct component of oral mucosal
immunity [14]. Wound healing within gingiva is characterized by rapid and fetal-
like scarless healing, contrary to the common scar formation in skin [15]. Gingival
tissue is easily assessable and gingival cells can be easily isolated and expanded from
patients or healthy donors. Gingival fibroblast-like cells, including fibrocytes,
myofibroblasts, pericytes and mesenchymal stem cells, a heterogeneous group of
cells with distinct properties and functions, were named gingival fibroblasts before
2009, playing key roles in tissue development, maintenance and repair, as well as
contributing to various pathologies [16]. Zhang et al. was the first to isolate and
characterize a new population of precursor cells from human gingival tissues,
termed GMSCs, which exhibit three unique stem cell-like properties as MSCs
derived from bone marrow and other postnatal tissues [17]. Based on the minimal
characterization criteria for human MSCs of the International Society for Cellular
Therapy [18], the population of GMSCs shows: (1) in vitro proliferation as plastic-
adherent cells with fibroblast-like morphology, colony-forming ability,
(2) multipotent differentiation into different cell lineages, (3) positive expression of
MSCs surface markers and stem cell-specific genes, negative of hemopoietic stem
cell ones. Moreover, some studies reported that GMSCs manifested a higher expan-
sion and telomerase activity and kept the features of MSCs, morphology and normal
karyotype stable during cell expansion [19]. Recently, Gugliandolo et al. reported
that most oncogenes of GMSCs at higher passengers were turned off, suggesting
that long-term cultured GMSCs may be safer in the clinical setting [20].
Table 1.
Advantages of GMSCs in the treatment of immunological diseases compared to other MSCs according to the
updated studies.
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Table 1 summarizes the advantages of GMSCs obtained from current studies in the
treatment of immunological diseases.
3. Roles and mechanisms of GMSCs in treating immunological diseases
In response to the current challenges in the field of medicine on the efficacy and
serious adverse effects of the current treatments, researchers are investigating the
alternative therapies. In this regard, the use of MSCs represents a great promise for
the treatment of a variety of immune-related diseases due to their potent properties
of immunomodulatory ability [21, 22]. BMSCs and umbilical-cord MSCs (UC-
MSCs) are widely studied because of their low immunogenicity [12, 23]. GMSCs, as
a new subtype of MSCs, share strong abilities of immune regulation as MSCs from
other tissues [24, 25]. As to update these advances of researches in GMSCs, we
summarize the current recognition on the curative effects and mechanisms on
immune and inflammation-related diseases (Table 2).
3.1 Immunoregulatory properties of GMSCs on autoimmune diseases
Autoimmune diseases are caused by defects in immune tolerance, resulting in
that the body immune system failing to identify cells from their own or the foreign
accompanied by the cellular or tissue damage [26]. Autoimmune diseases are cate-
gorized into systemic or organ-specific types according to the extent of tissue
involvements [27]. The pathogenesis of autoimmune diseases is still not well-
understood as multifactorial factors may be involved in at least both genetic and
environmental factors [28, 29]. Although the conventional and biological therapies
can somehow ameliorate clinical symptoms and decrease the morbidity and mor-
tality, the limited efficiency, bone marrow toxicity and other side effects including
infection and tumor are problematic [30]. Therefore it is desirable to find new
strategies that can cure autoimmune diseases with minimal side effects. The MSCs
therapy has been demonstrated to be likely as a new alternative approach. As a
subset of MSCs, current studies show that GMSCs have even strong and better
immunoregulatory effects than MSCs derived from other sources, through cell-cell
contacting or secreting molecules to modulate both innate and adaptive
responses [31].
Type 1 Diabetes Mellitus (T1DM) is an autoimmune disorder resulted from T
cell-mediated destruction of pancreatic β-cells [32]. Hu et al. reported a clinical trial
that implantation of Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs)
from the umbilical cord for newly-onset T1DM restored the function of islet β-cells
in a longer time by improving the level of HbA1c and C peptide without acute or
chronic side effects, suggesting that the implantation of WJ-MSCs for the treatment
of newly-onset T1DM is safe and effective [33]. Researches in experimental models
of mice manifested that MSCs inhibited the expansion of Th1, Th17 cells and
stimulated the proliferation of CD4+CD25+Foxp3+ T regulatory (Treg) cells by
reducing the levels of pro-inflammatory cytokines such as TNF-α, IFN-γ, CCL2,
IL-1β, IL-2 and IL-17 but increasing the expression of immunoregulatory cytokines
such as IL-4, IL-10 and IL-13 [9]. Zhang et al. infused GMSCs to determine the
therapeutic effect on T1DM model, just as other MSCs, showed that GMSCs
administration, homing to pancreas lymph nodes and pancreas, could delay diabe-
tes onset, ameliorate pathology in pancreas by regulating down IL-17 and IFN-γ of
CD4+ and CD8+ T cell and induce the generation of induced regulatory T (iTreg)
in vivo which may be regulated through CD39/CD73 signal pathway [34]. Treg cells
are a crucial immune suppressor that maintains the immune tolerance and prevents
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Table 2.
List of studies in which the therapeutic potential of administration of GMSCs for the treatment of
immunological diseases was obtained.
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the autoimmune responses [35–37]. It was also observed in rheumatoid arthritis
animal model where GMSCs promoted Treg cell development to control autoim-
mune arthritis [38]. Some investigators also identified that high exocytotic fusion
by secreting exosomes and cytokines is an alternative mechanism of GMSCs to
promote the wound healing in diabetic patients, one of the most challenging com-
plications in clinical medicine [39, 40].
The utilization of MSCs has reduced both the severity of disease and histopa-
thology scores in rheumatoid arthritis models [9]. In collagen-induced arthritis
(CIA) models, Chen et al. demonstrated that the adoptive transfer of GMSCs
significantly delayed the onset of CIA and decreased the severity scores [38]. His-
tological and quantitative analysis of ankle joints demonstrated a significant
decrease in synovitis, pannus formation and destruction of bone and cartilage in
treated mice by increasing iTreg cells frequency while reducing percentages of Th1
and Th17 cells and relevant pro-inflammatory cytokines IFN-γ, IL-17, and TNF-α.
Interestingly, Th2-type IL-4, IL-5 and IL-13 were not affected [38]. They found that
GMSCs exerted the immune suppression functions indirectly via adenosine through
CD39/CD73 signaling [38]. Recently, Gu et al. further supported this finding that
GMSC ameliorated CIA and revealed that GMSC mediated T-cell apoptosis and
influenced the polarization of the Th cells via a FasL/Fas pathway, resulting in
immune tolerance and ameliorating the severity of CIA in mice [41].
3.2 Immunoregulation of GMSCs on graft-versus-host disease
Allogenic graft-versus-host disease (allo-GVHD) is a severe complication of
organ or bone marrow transplantation related to the activation of alloreactive T cells
or autoreactive mechanisms [42–44]. In clinical trials and experimental models, the
administration of MSCs from bone marrow, adipose tissue and others decreased the
severity of the symptoms and increased the survival. Most studies reported that
MSCs inhibit reactive T cells trafficking and their proliferation. In addition, MSCs
also stimulate cells differentiation into immunomodulatory cells such regulatory
dendritic cells, Treg, Breg cells and M2 macrophages [9]. There is only a research of
GMSCs for the treatment of allo-GVHD in mice model. Huang et al. revealed that
GMSCs displayed the superior effect to BMSCs on suppressing xeno-GVHD
according to the weight loss and inflammatory pathology in liver, lung, and intes-
tine [45]. The underlying mechanism may be that GMSCs inhibited lymphocytes
proliferation through CD39/CD73/adenosine and/or IDO signals without influenc-
ing CD4+Foxp3+ Treg cells [45].
3.3 Therapeutic progression of GMSCs in other inflammatory diseases
Inflammatory bowel disease characterized by dysfunction of the innate and
adaptive immunity is a group of inflammatory conditions of the colon and small
intestine [46–48]. The existing studies demonstrated administration of MSCs
inhibited the proliferation and infiltration of inflammatory cells, for instance, sig-
nificant inhibition in the expansion of Th1 and Th17 cells and opposite effect in the
clonal expansion of Treg, by two main ways: direct cell-cell contact and the release
of soluble factors [9]. In line with other tissues-derived MSCs, systemic infusion of
GMSCs protected mice from colitis related tissue injuries and reduced the overall
disease severity. Zhang et al. confirmed that GMSCs suppressed CD4+ T lympho-
cyte and promoted regulatory T cells infiltration to the colonic sites, which was
accelerated by IFN-β-induced IDO and IL-10 [17]. While Yang et al. exhibited other
actions of GMSCs in colitis that hydrogen sulfide upregulated the expression of
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Fas/FasL in GMSCs coupling-induced T cells migration and T-cell apoptosis to
maintain immunomodulation of GMSCs in vivo and in vitro [49].
Atherosclerosis is the major cause of cardiovascular diseases. Current evidences
indicate that inflammation is involved in the pathogenesis of atherosclerosis and
monocytes/macrophages are the major inflammatory cells [50]. Zhang et al. firstly
indicated that GMSCs decreased inflammatory level, plaque size and lipid deposi-
tion in mice model in vivo, partly by inhibiting macrophage foam cell formation,
suppressing the activation of M1 macrophages and promoting their development
into the M2 phenotype via IDO and CD73 signals [51].
Periodontitis is a widespread bacterially induced immune-inflammatory disorder
of the periodontium, featured with a progressive destruction of the tooth-supporting
structures [52]. The milieu of bacterial biofilms challenges and activates host innate
and adoptive immune systems to produce pro-inflammatory cytokines and
chemokines for inflammatory cells recruitment, striking the balance of osteoblast and
osteoclast [53]. MSCs from bone marrow, adipose, dental pulp and periodontal liga-
ment have been testified to, in vivo, newly form periodontal bones, collagen fibers,
periodontal ligament-like tissue and cementoid tissue indicating periodontium
regeneration [54]. GMSCs also were proved to generate new cementum-like tissue,
bone and sharpey fibers in dog and pig model of periodontitis [55, 56].
3.4 The contribution of GMSCs to contact hypersensitivity
Murine contact hypersensitivity (CHS) as a model similar to human allergic
contact is caused by delayed-type hypersensitivity responses to antigens that come
into contact with the skin [57]. The pathological process consists of sensitization
phase, the elicitation or challenge phase, and resolution/regulation phase [58]. In
this process, allergen-specific effector T cells and various types of innate immune
cells are involved [59]. In 2011, Su et al. investigated the immunoregulatory role of
GMSCs and for first time found that i.v. injection of GMSC significantly attenuated
the CHS appearance at different phases of CHS, and showed that GMSCs-derived
PGE2 played a crucial role in their inhibitory effect on dendritic cells and mast cells
[60]. Li et al. further testified that PGE2–EP3 signaling played an important role in
the immunomodulatory functions of GMSCs in murine CHS [61].
3.5 Wound healing
Cutaneous wound healing involves in three phases: inflammation, tissue forma-
tion, and remodeling [62]. Studies have demonstrated that systemically injected
MSCs can home to injury sites accelerating wound repair [63]. Because of the rapid
and fetal-like healing of gingival trauma, researchers have focused on the effect and
mechanism of GMSCs. Experiments in vitro suggested that GMSCs were capable of
switching macrophages from classical activation or proinflammatory M1 phenotype
to an anti-inflammatory profile of M2 macrophages by soluble factors such IL-6,
COX-2 and GM-CSF [64]. In vivo mice model suggested that enhancement of
wound healing by systemic infusion of GMSCs related to enhanced re-
epithelialization, collagen deposition and angiogenesis [64]. Compared with
BMSCs, Linard et al. reported that gingival fibroblasts (GFs) intradermally injected
in irradiated skin induced earlier development of thick, fully regenerated epider-
mis, skin appendages and hair follicles [65]. GFs also modified expression of ECM-
related gene, ECM components (tenascin-C and a-smooth muscle actin) and wound
healing-related factors, like TGF-β1 and CTGF [65]. While the influence to macro-
phage recruitment and differentiation of GFs was in accordance with Zhang et al.,
other studies presented that GMSC-derived exosomes accelerated wound healing in
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a diabetic rat skin defect model [39, 40]. Kou et al. indicated that TNF-α-Fas/Fap-1
via the NF-κB pathway enhancing IL-1RA release in GMSCs participated in healing
progress [40].
4. Analysis of factors influencing the function of GMSC
Only well preserved the comprehensive and stable features, GMSCs can be an
alternative cell therapy to autoimmune and inflammation-related diseases. Many
factors can disturb the functions of GMSCs. Su et al. reported disturbed oral
microbiome weakened the wound healing of GMSCs through miR-21/Sp1/telome-
rase reverse transcriptase pathway [66]. The physical condition of donors is a key
factor to properties of GMSCs. Assem et al. revealed that GMSCs exhibited a greater
proliferation rate and higher surviving in normal individuals than the diabetic
patients [67]. Moreover, GMSCs exosome from diabetic mice showed reduced
IL-1RA and decreased Fas expression when compared to WT GMSCs [40]. Differ-
ent culture techniques of GMSCs have a profound effect on their biological func-
tions. Subbarayan et al. showed that GMSCs derived spheroids enhanced abilities of
viability, pluripotency and multi-lineages and maintained the properties of stem
cells convincingly than conventional culture methods [68]. Zhang et al. have con-
firmed that spheroid-derived GMSCs possessed better therapeutic efficacy than
their adherent counterpart [69]. The spheroid-derived GMSCs also had a greater
homing ability to mucositis sites and underwent a higher mesenchymal-epithelial
transformation compared to conventional culture GMSC in murine model of
chemotherapy-induced oral mucositis [69]. Although normal and inflammatory
GMSCs similarly expressed mesenchymal stem cells markers and proliferation abil-
ity, inflammatory microenvironments indeed reduced differentiation potentials of
GMSCs [70]. Zhang et al. demonstrated that initial inflammatory stimuli of IL-1 and
TNF-α appeared essential for GMSCs proliferation and tissue regeneration, while
with inflammatory persistence, this effect turned to osteogenesis followed by a
short-term stimulatory [71]. However, Apatzidou et al. demonstrated that GMSCs
from periodontal granulation tissue possessed similar immunophenotype and
regeneration feature to those in healthy periodontal tissue [72]. Many studies have
also demonstrated that other elements also affect the biological characteristics of
GMSCs, for instance, Lee et al. reported that dexamethasone accelerated the aging
of GMSCs through downregulating SIRT1 and IL6 and upregulating EDN1 genes via
the AGE/RAGE pathway [73]. In addition, hypoxic enhanced the suppressive
effects of GMSCs on peripheral blood mononuclear cells and inhibited the local
inflammation of injured skin by suppressing the inflammatory cells, accompanying
with reduction of TNF-α and increase of IL-10 [74].
5. Conclusion
The existing studies have documented that GMSCs have self-renewal,
multi-lineage differentiation potential, and immunomodulatory properties. These
properties make GMSCs an alternative cell-based therapy of autoimmune and
inflammation-related diseases. Plenty of internal and external factors may affect
their functions of renewal, regeneration and immunoregulation. Moreover, the
specific mechanisms and clinical efficacies are indistinct. Future studies and
clinical trials should be implemented to elaborate mechanisms and therapeutic
effects of immunomodulatory properties in detail on various inflammatory and
immunological diseases.
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